Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies

Gastroenterology. 2021 Aug;161(2):715-718.e4. doi: 10.1053/j.gastro.2021.04.025. Epub 2021 Apr 20.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Adult
  • Aged
  • Antibodies, Viral / blood*
  • BNT162 Vaccine
  • Biological Products / therapeutic use*
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / immunology*
  • Case-Control Studies
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Inflammatory Bowel Diseases / drug therapy*
  • Male
  • Middle Aged
  • RNA, Messenger
  • SARS-CoV-2 / immunology
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology*
  • Young Adult

Substances

  • Antibodies, Viral
  • Biological Products
  • COVID-19 Vaccines
  • Immunoglobulin G
  • RNA, Messenger
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine